1H,5H-Benzo[ij]quinolizine-2-carboxylic acid, 9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-

CAS: 124858-35-1

Ref. AN-AG000MTZ

Informação sobre produto

• Nome: 1H,5H-Benzo[ij]quinolizine-2-carboxylic acid, 9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-
• Sinónimos: [u'9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidyl)-5-methyl-1-oxo-1H,5H-benzo(i,j)quinolizine-2-carboxylic acid', u'nadifloxacin', u'OPC 7251', u'OPC-7251', u'R-NDFX', u'S-NDFX', u'nadifloxacin', u'124858-35-1', u'jinofloxacin', u'OPC-7251', u'Acuatim', u'Nadixa', u'S-Nadifloxacin', u'Nadifloxacine', u'Nadifloxacino', u'Nadifloxacinum', u'NDFX', u'Opc 7251', u'Nadifloxacine [INN-French]', u'Nadifloxacinum [INN-Latin]', u'Nadifloxacino [INN-Spanish]', u'CCRIS 4066', u'C19H21FN2O4', u'CHEBI:31889', u'NCGC00164620-01', u'DSSTox_CID_26483', u'DSSTox_RID_81654', u'DSSTox_GSID_46483', u'(+/-)-9-fluoro-6,7-dihydro-8-(4-hydroxypiperidino)-5-methyl-1-oxo-1h,5h-benzo[ij]quinolizine-2-carboxylic acid', u'(+-)-9-Fluoro-6,7-dihydro-8-(4-hydroxypiperidino)-5-methyl-1-oxo-1H,5H-benzo(ij)quinolizine-2-carboxylic acid', u'1H,5H-Benzo[ij]quinolizine-2-carboxylicacid, 9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-', u'9-fluoro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1,5,6,7-tetrahydropyrido[3,2,1-ij]quinoline-2-carboxylic acid', u'9-fluoro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-6,7-dihydro-1H,5H-pyrido[3,2,1-ij]quinoline-2-carboxylic acid', u'CAS-124858-35-1', u'SR-05000001516', u'UNII-6CL9Y5YZEQ', u'Nadoxin', u'Nadifloxacin [BAN:INN:JAN]', u'Nadifloxacin [INN:BAN:JAN]', u'Acuatim (TN)', u'ACMC-20f8qx', u'Nadifloxacin (JAN/INN)', u'6CL9Y5YZEQ', u'AC1L1I3S', u'AC1Q5RD5', u'SCHEMBL36593', u'MLS002154166', u'CHEMBL363449', u'DTXSID5046483', u'CTK0H5989', u'OPC7251', u'JYJTVFIEFKZWCJ-UHFFFAOYSA-N', u'HMS2090D11', u'HMS2098O22', u'HMS2233D22', u'HMS3373H17', u'HMS3651J22', u'HMS3715O22', u'Pharmakon1600-01502312', u'BCP05205', u'HY-B0506', u'KS-00000L1W', u'Tox21_112239', u'MFCD00865081', u'NSC759622', u's3105', u'AKOS015895271', u'Tox21_112239_1', u'AC-4283', u'API0003479', u'BCP9000975', u'CCG-213817', u'CS-2707', u'DB12447', u'KS-1210', u'NSC-759622', u'VA11339', u'NCGC00164620-02', u'AK481275', u'AN-12142', u'CC-32334', u'H946', u'SC-65524', u'SMR001233465', u'AB0013377', u'LS-172604', u'RT-017497', u'FT-0082822', u'FT-0631118', u'N0931', u'SW199586-2', u'D01147', u'AB00918517-07', u'AB00918517_08', u'AB00918517_09', u'858N351', u'C-20888', u'I06-0769', u'J-005176', u'SR-05000001516-1', u'SR-05000001516-3', u'8-(4-hydroxy-1-piperidyl)-9-fluoro-5-methyl-6,7-dihydro-1-oxo-1H,5H-benzo[ij]quinolizine-2-carboxylic acid', u'8-Fluoro-5,6-dihydro-7-(4-hydroxypiperidino)-4-methyl-1-oxo-4H-3a-aza-1H-phenalene-2-carboxylic acid', u'81962-84-7', u'9-Fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-1H,5H-benzo[ij]quinolizine-2-carboxylic Acid', u'9-Fluoro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-1,5,6,7-tetrahydropyrido[3,2,1-ij]quinoline-2-carboxylic Acid', u'9-fluoro-8-(4-hydroxy-1-piperidyl)-5-methyl-6,7-dihydro-1-oxo-1H,5H-benzo[ij]quinolizine-2-carboxylic acid', u'CID4410', u'AR-1J2863', u'C19-H21-F-N2-O4', u'CS-O-30686', u'12772-35-9'], (±)-9-Fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-1H,5H-benzo[ij]quinolizine-2-carboxylic Acid, 124858-35-1, 9-Fluoro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-6,7-dihydro-1H,5H-pyrido[3,2,1-ij]quinoline-2-carboxylic acid, Jinofloxacin, Nadibact, Nadixa, Opc 7251
• CAS: 124858-35-1
• Marca: Indagoo

Propriedades químicas

• Peso molecular: 360.3794
• Fórmula: C₁₉H₂₁FN₂O₄
• Pureza: 98%
• Cor/forma: Solid
• InChI: InChI=1S/C19H21FN2O4/c1-10-2-3-12-16-13(18(24)14(19(25)26)9-22(10)16)8-15(20)17(12)21-6-4-11(23)5-7-21/h8-11,23H,2-7H2,1H3,(H,25,26)
• Chave InChI: JYJTVFIEFKZWCJ-UHFFFAOYSA-N